דלג לתוכן
  • Contact Us
  • פייסבוק אתר החברה
Israel Medical Association – The Society for the Study, Prevention, and Treatment of Atherosclerosis
Israel Medical Association – The Society for the Study, Prevention, and Treatment of Atherosclerosis
Israel Medical Association – Society for Research, Prevention and Treatment of Atherosclerosis
  • Home Page
  • About us
  • Conferences
  • Conferences coverage
  • Contact Us
  • Hebrew
  • Home Page
  • About us
  • Conferences
  • Conferences coverage
  • Contact Us
  • Hebrew
Israel Medical Association – The Society for the Study, Prevention, and Treatment of Atherosclerosis
  • Home Page
  • About us
  • Conferences
  • Conferences coverage
  • Contact Us
  • Hebrew
  • Home Page
  • About us
  • Conferences
  • Conferences coverage
  • Contact Us
  • Hebrew
ראשי » 2025 » November

Archive for November 2025

Annual 2025 Lectures

מערכת האתר 24 בNovember 2025 11:11 Comments Off on Annual 2025 Lectures

Here are the lectures from the conference held on 23-24.10.2025 Click here for the program Here is a link to

Read More »

Keynote Lecture: “Why Lower Triglycerides?”

מערכת האתר 24 בNovember 2025 11:09 Comments Off on Keynote Lecture: “Why Lower Triglycerides?”
Read More »

Familial Hypercholesterolemia in a Multi-Ethnic Regional Health Service: Ten Years Follow Up

מערכת האתר 24 בNovember 2025 11:08 Comments Off on Familial Hypercholesterolemia in a Multi-Ethnic Regional Health Service: Ten Years Follow Up
Read More »

Literature Review Regarding the use of Psychiatric Medications and their Effect on Lipid Profile, Particular Attention to Child and Adolescent Psychiatric Treatments

מערכת האתר 24 בNovember 2025 11:06 Comments Off on Literature Review Regarding the use of Psychiatric Medications and their Effect on Lipid Profile, Particular Attention to Child and Adolescent Psychiatric Treatments
Read More »

Keynote Lecture: Real World Effective Options for LDL-C Management in Patients with Homozygous Familial Hypercholesterolemia

מערכת האתר 24 בNovember 2025 11:05 Comments Off on Keynote Lecture: Real World Effective Options for LDL-C Management in Patients with Homozygous Familial Hypercholesterolemia
Read More »

Session 4: Old and Emerging Risk Factors

מערכת האתר 24 בNovember 2025 11:03 Comments Off on Session 4: Old and Emerging Risk Factors

Chairpersons: Cohen Hofit & Claudia Stefanutti

Read More »

Lifetime Achievement Award to Prof. Yaakov Henkin | Update on Guidelines from the Last ESC 2025

מערכת האתר 24 בNovember 2025 11:01 Comments Off on Lifetime Achievement Award to Prof. Yaakov Henkin | Update on Guidelines from the Last ESC 2025
Read More »

A Unique case for use of Evkeeza

מערכת האתר 24 בNovember 2025 10:58 Comments Off on A Unique case for use of Evkeeza
Read More »

New Horizons for Treatments of Atherosclerosis (from LDL to Lp(a))

מערכת האתר 24 בNovember 2025 10:56 Comments Off on New Horizons for Treatments of Atherosclerosis (from LDL to Lp(a))
Read More »

Anti-Inflammatory Agents in Atherosclerosis: Performing or Underperforming?

מערכת האתר 24 בNovember 2025 10:54 Comments Off on Anti-Inflammatory Agents in Atherosclerosis: Performing or Underperforming?
Read More »
  • 1
  • 2
  • 3
מידע כללי
  • About us
  • Regulations
  • Contact Us
  • ארכיון
לאתר עמותת לכ"ם
לדף הפייסבוק של עמותת לכ"ם

Association Sponsors:

  • Contact Us
  • Regulations
  • Terms of Use
Powered by e-med.co.il
© The Society for the Study, Prevention, and Treatment of Atherosclerosis | All rights reserved

התאמות נגישות

ניתן להשתמש בחצי המקלדת ובמקש Esc לפתיחה וסגירה.

שפה
צבע וניגודיות
התאמות תצוגה
סמן
גודל מלל
0
הגדלת תצוגה
0
מקשי קיצור
  • מקש Esc — פתיחה וסגירה של הסרגל
  • Ctrl + — הגדלת מלל באתר
  • Ctrl − — הקטנת מלל באתר
  • Ctrl 0 — החזרת הגודל המקורי
  • מקש רווח — גלילה כלפי מטה
  • F11 — מסך מלא (לחיצה נוספת מבטלת)
הצגת הצהרת נגישות

דיווח על בעיית נגישות

Scroll to top

Welcome to the website of the Israeli Society for the Research, Prevention, and Treatment of Atherosclerosis.

Access to the site is permitted solely for physicians licensed to practice medicine in Israel
and/or licensed pharmacists and/or individuals who are members of medical or biomedical research staff.